Close

Microglia become hypofunctional and release metalloproteases and tau seeds after phagocytosing live neurons with P301S tau aggregates

Jack H. Brelstaff, Matthew Mason, Taxiarchis Katsinelos, William A. McEwan, Bernardino Ghetti, Aviva M. Tolkovsky, Maria Grazia Spillantini

Preprint posted on 26 February 2021 https://www.biorxiv.org/content/10.1101/2021.02.26.433088v1

The bitter taste of tau: how microglia “eating” neurons with tau aggregates may contribute to disease pathology and spreading in tauopathies

Selected by Kristina Kuhbandner

Categories: neuroscience

Background

Aggregation of the protein tau is observed in several human neurodegenerative diseases including Alzheimer’s disease, frontotemporal dementia (FTD) and Pick’s disease. These tauopathies are characterized by neuronal cell death associated with intracellular tau aggregates (1). The exact mechanism of cell death and spreading of tau in the central nervous system (CNS) remains unclear, but there is evidence that microglia, the resident immune cells in the brain, are involved (2).

Amongst others, activated microglia help to remove damaged or dying cells in the CNS by engulfing them in a process known as phagocytosis. This is triggered by the exposure of “eat-me” signals like phosphatidylserine (PtdSer) on the damaged cells (3). Previously, the Spillantini lab investigated phagocytosis in co-cultures of microglia with neurons isolated from P301S tau transgenic mice. Due to the expression of mutant tau protein, these mice develop neuronal tau aggregates starting at the age of 3 months (4). The respective study revealed that living neurons with tau inclusions exhibit abnormally high amounts of PtdSer marking them for phagocytosis by microglia (5). Using the same model, in this pre-print Brelstaff et al. analyzed microglia that phagocytosed tau-containing neurons in more detail.

 

Key results

  • Microglia phagocytosing neurons with tau aggregates release tau

First, microglial cells from C57BL/6 wildtype mice were cultured with neurons isolated from 5-month-old P301S tau transgenic mice (P301S neurons). After several days, a significant amount of tau was detected in the supernatant of these co-cultures. Blocking phagocytosis by masking PtdSer markedly reduced the loss of neurons and the presence of tau in the medium indicating that phagocytosing microglia were the source of tau. Remarkably, microglia continued to release tau when re-isolated from the neuronal co-cultures.

  • Released tau is insoluble and can trigger seeding of tau aggregates

Then, they further characterized tau detected in co-culture medium. Similar to tau in P301S neurons, tau in the supernatant was present in the form of insoluble aggregates. Of note, the isolated species were also able to induce aggregation in a tau seeding assay.

  • After phagocytosing tau aggregate-containing neurons microglia become hypophagocytic and    adopt a senescence-like state

To determine the phagocytic capacity of microglia after ingesting P301S neurons, microglia were re-isolated and cultured again in the presence of fresh P301S neurons. In this setting, no significant loss of tau aggregate-containing neurons was observed indicating a hypophagocytic phenotype which renders microglia unable to engulf other neurons with tau aggregates. Additionally, these microglia showed an increase in acidic β-galactosidase activity, a marker for cellular senescence.

  • Hypophagocytic microglia release a specific protein profile enriched in MMP3

Next, a proteome array was performed on co-culture medium to identify proteins associated with the observed alterations in microglia functionality. While microglial monocultures released proteins such as CCL2, CCL6 and VEGF, addition of LPS induced a more inflammatory phenotype including TNFα expression. In contrast, no pro-inflammatory cytokines were detected in the medium of untreated P301S neuron-microglia co-cultures. Instead, several senescence-associated factors were secreted with matrixmetalloprotease 3 (MMP3) being the topmost upregulated. Consequently, the authors analyzed MMP3 expression in mouse and human brain tissue associated with tauopathies. Its active form was not only found to be upregulated in aged P301S mice but also in the brain of patients with different neurodegenerative diseases such as FTD and Pick’s disease.

  • MMP3 expression is regulated by the NFκB pathway

Several of the upregulated proteins are controlled by the NFκB pathway. To test whether this also applies to MMP3, microglia were pre-treated with an NFκB pathway inhibitor; this resulted in a reduction of MMP3 in the culture medium. Interestingly, inhibition of phagocytosis did not decrease MMP3 production indicating that PtdSer-signalling is not involved in MMP3 activation.

Graphical summary

 

Figure 1. Potential role of microglia in a vicious cycle after phagocytosing neurons with tau aggregates.

Microglia that have phagocytosed tau aggregate-containing neurons acquire a hypophagocytic, senescence-like state and might enhance tau pathology by spreading tau aggregates (taken from Brelstaff et al., 2020, Fig. 5, made available under a CC-BY-NC 4.0 International license).

 

Why I chose this preprint

There are several reasons why I highlighted this pre-print. First, in combination with previous findings, this study contributes to the understanding of cell death mechanisms and the spreading of tau aggregates in tauopathies. Moreover, it provides further evidence that preventing neurodegeneration and phagocytosis is a promising treatment strategy for tauopathies. Second, one of my research projects deals with phagocytosis of PtdSer-expressing living motor neurons in the context of amyotrophic lateral sclerosis, another neurodegenerative disease with characteristic protein aggregations. Thus, I am curious whether the reported results are also applicable to other tau-independent neurodegenerative disorders. Third, March 8th is celebrated as International Women’s Day. In most professions, including academia and science, women are still underrepresented at higher career stages. Early data suggest that the COVID-19 pandemic especially affected the work of female scientists and could widen the gender gap (6). Here, I like to emphasize that this study is led by Maria Gracia Spillantini, a renowned female neuroscience expert who is probably best known for identifying alpha-synuclein as disease-associated aggregation-prone protein in Parkinson’s disease. With her remarkable achievements and her extremely successful academic career, she is an encouraging role model inspiring many young scientists.

 

Questions to the authors

  • In your co-culture setting naïve microglia from C57BL/6 mice were used. Do you expect microglia isolated from aged P301S mice to behave different? Are there indications that these have already adopted a senescent-like state as you observed for naïve microglia after culture with P301S neurons?
  • The findings of this study are mainly based on the analysis of culture media. Do you also plan to further characterize senescent microglia, for example by RNAseq?
  • Phagocytosis of living neurons is a phenomenon observed in various neurodegenerative diseases (3). Can you speculate to what extend your findings might also be transferable to other diseases involving protein aggregates such as Parkinson’s disease or amyotrophic lateral sclerosis?
  • Spillantini, you have started your enormously successful career more than 30 years ago. Do you think that today achieving a meaningful position in academia as female scientist is easier and if so, why? What needs to be done in the future in this regard?

 

Literature

  1. Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013 Jun 1;12(6):609–22.
  2. Perea JR, Llorens-Martín M, Ávila J, Bolós M. The Role of Microglia in the Spread of Tau: Relevance for Tauopathies. Front Cell Neurosci [Internet]. 2018 [cited 2021 Mar 6];12. Available from: https://www.frontiersin.org/articles/10.3389/fncel.2018.00172/full
  3. Brown GC, Neher JJ. Microglial phagocytosis of live neurons. Nat Rev Neurosci. 2014 Apr;15(4):209–16.
  4. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, et al. Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein. J Neurosci. 2002 Nov 1;22(21):9340–51.
  5. Brelstaff J, Tolkovsky AM, Ghetti B, Goedert M, Spillantini MG. Living Neurons with Tau Filaments Aberrantly Expose Phosphatidylserine and Are Phagocytosed by Microglia. Cell Rep. 2018 Aug 21;24(8):1939-1948.e4.
  6. Woitowich NC, Jain S, Arora VM, Joffe H. COVID-19 Threatens Progress Toward Gender Equity Within Academic Medicine. Acad Med J Assoc Am Med Coll. 2020 Sep 29;

 

 

Tags: microglia, neuronal cell death, phagocytosis, tauopathies

Posted on: 11 March 2021

doi: https://doi.org/10.1242/prelights.27633

Read preprint (2 votes)

Have your say

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign up to customise the site to your preferences and to receive alerts

Register here

preLists in the neuroscience category:

‘In preprints’ from Development 2022-2023

A list of the preprints featured in Development's 'In preprints' articles between 2022-2023

 



List by Alex Eve, Katherine Brown

CSHL 87th Symposium: Stem Cells

Preprints mentioned by speakers at the #CSHLsymp23

 



List by Alex Eve

Journal of Cell Science meeting ‘Imaging Cell Dynamics’

This preList highlights the preprints discussed at the JCS meeting 'Imaging Cell Dynamics'. The meeting was held from 14 - 17 May 2023 in Lisbon, Portugal and was organised by Erika Holzbaur, Jennifer Lippincott-Schwartz, Rob Parton and Michael Way.

 



List by Helen Zenner

FENS 2020

A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020

 



List by Ana Dorrego-Rivas

ASCB EMBO Annual Meeting 2019

A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)

 



List by Madhuja Samaddar et al.

SDB 78th Annual Meeting 2019

A curation of the preprints presented at the SDB meeting in Boston, July 26-30 2019. The preList will be updated throughout the duration of the meeting.

 



List by Alex Eve

Autophagy

Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.

 



List by Sandra Malmgren Hill

Young Embryologist Network Conference 2019

Preprints presented at the Young Embryologist Network 2019 conference, 13 May, The Francis Crick Institute, London

 



List by Alex Eve
Close